Clinical Trials in Weinan, Shaanxi
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Treatment ResponseHigh-risk Prostate CancerPSMA PET+1 more
Xijing Hospital110 enrolled9 locationsNCT07553780
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
bone metastasisPSMA PETProstate Cancer (Diagnosis)+4 more
Xijing Hospital1,000 enrolled9 locationsNCT07553754
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Molecular ImagingSuspected Prostate CancerTreatment-naive Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07531329
Recruiting
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Clinically Significant Prostate Cancer
Xijing Hospital1,700 enrolled10 locationsNCT07492927
Recruiting
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07474142
Recruiting
Not Applicable
68Ga-PSMA PET in the Renal Cell Carcinoma
MetastasesRenal CancerPSMA PET
Xijing Hospital300 enrolled9 locationsNCT04987086
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138